Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Genmab A/S CPSE:GMAB |
107,96 B | 14,29% | 4/6 | -4,48% | 52,86% | 33,64% | DOWN |
|
Ascendis Pharma A/S NasdaqGS:ASND |
14,07 B | 144,29% | 4/6 | 91,21% | 89,60% | 24,99% | UP |
|
Zealand Pharma A/S CPSE:ZEAL |
21,04 B | 71,10% | 4/6 | -51,93% | 89,70% | 67,79% | DOWN |
|
Bavarian Nordic A/S CPSE:BAVA |
15,13 B | 21,29% | 5/6 | -21,10% | 18,14% | 40,52% | DOWN |
|
BioPorto A/S CPSE:BIOPOR |
0,44 B | -11,13% | 2/4 | 0,00% | 28,69% | -100,00% | DOWN |
|
FluoGuide A/S OM:FLUO |
0,62 B | 0,00% | 2/4 | 0,00% | 0,00% | 95,99% | DOWN |
|
Evaxion A/S NasdaqCM:EVAX |
0,03 B | 0,00% | 0/0 | -47,94% | -151,06% | 164,55% | DOWN |
|
Initiator Pharma A/S OM:INIT |
0,21 B | 0,00% | 2/4 | 0,00% | 0,00% | 208,41% | DOWN |
|
Strategic Partners A/S CPSE:STRAP |
0,03 B | 0,00% | 3/4 | 0,00% | 0,00% | -100,00% | DOWN |
|
IO Biotech NasdaqGS:IOBT |
0,00 B | 0,00% | 0/0 | 0,00% | 0,00% | 7166,67% | DOWN |
|
Scandion Oncology A/S BST:8VY |
0,00 B | 0,00% | 3/4 | 0,00% | 0,00% | 0,00% | DOWN |
|
Forward Pharma A/S OTCPK:FWPA.Y |
0,00 B | 0,00% | 0/0 | 0,00% | 0,00% | -100,00% | DOWN |
